Research Alliance Corp III SEC filings RACC
Research Alliance Corp III has 45 filings in SEC EDGAR's recent list, going back to Mar 24, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 27, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Nov 4, 2026 | — |
| S-4/A | Filing | Oct 30, 2026 | — |
| S-4/A | Filing | Sep 28, 2026 | — |
| S-4 | Registration for a merger or exchange | Aug 24, 2026 | — |
| 424B4 | Prospectus | May 20, 2026 | — |
| S-1/A | Amended registration statement | May 13, 2026 | — |
| S-1/A | Amended registration statement | Apr 23, 2026 | — |
| S-1 | Registration statement | Mar 24, 2026 | — |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RACC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2118032
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.